Proceedings of the 27th Annual Meeting of the Japanese Association for Biotherapeutics

Preface

This special issue of ANTICANCER RESEARCH presents the Proceedings of the 27^th Annual Meeting of the Japanese Association for Biotherapeutics. It is our great pleasure to introduce this issue expressing my sincere gratitude to the Editors of Anticancer Research for kindly accepting and publishing the proceedings of our regional meeting in Japan in ANTICANCER RESEARCH.

The 27^th meeting was held in Fukuoka, Japan on December 2, 2023, chaired by Dr. Masato Watanabe, Professor, Department of Surgery, Chikushi Hospital, Fukuoka University, Fukuoka, Japan and Dr. Shin’ichiro Yasunaga, Professor, Biochemistry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

This year’s special lectures were given by Professor Fusanori Yotsumoto, Department of Obstetrics and Gynecology, Fukuoka University, Fukuoka, Japan, on the theme of “Bioresearch x AI Analysis ~Challenges in the field of obstetrics and gynecology~”. In addition, there were many oral presentations on a wide range of basic and clinical topics, offering impressive advances in this field.

The main aims of our Society are to facilitate good communication between researchers and clinicians, and to perform clinical trials with adequate informed consent in an appropriate and professional manner. These aspects include important issues for the progress of biotherapy as well as for medicine in general. It is our sincere hope that these Proceedings will contribute to further progress in the field of biotherapy and that our members will continue to foster the aims of our Society.

Takeo Fukushima, Ph.D. & M.D.

President of the Japanese Association for Biotherapeutics (JAB)